Publications by authors named "David Sas"

Claim this Profile
U
Urine Oxalate Excretion and CKD Stage in Patients With Primary Hyperoxaluria Type 1.
Lisa E Vaughan, Phillip J Schulte, Felix Knauf, David J Sas, Dawn S Milliner

Am J Kidney Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and Clinical Characterization of a Large Cohort with Suspected Monogenic Stone Disease.
Andrea G Cogal, Ahmed E Ali, Muhammad G Arnous, Abdulmueti Alhadi, Le-Ting Zhou, David J Sas

Clin J Am Soc Nephrol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Physician Demographics on Patient Satisfaction Survey Results in Pediatrics: A Role for Implicit Bias?
David J Sas, Imad Absah, Sean M Phelan, Avni Y Joshi, Ana L Creo

Clin Pediatr (Phila)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Minor Haplotype Variant Determines the Pathogenicity of the p.Ile279Thr Substitution in the Primary Hyperoxaluria Type 1 Gene, AGXT.
Luana Ruta, Andrea G Cogal, Gioena Pampalone, David J Sas, John C Lieske

J Inherit Metab Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nedosiran in pediatric patients with PH1 and relatively preserved kidney function, a phase 2 study (PHYOX8).
David J Sas, Sevcan A Bakkaloglu, Vladimir Belostotsky, Wesley Hayes, Gema Ariceta

Pediatr Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of primary hyperoxalurias: best practices.
Mini Michael, Elizabeth Harvey, Dawn S Milliner, Yaacov Frishberg, David J Sas

Pediatr Nephrol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities in Primary and Enteric Hyperoxaluria at the Cross-Roads Between the Clinic and Laboratory.
Barbara Cellini, Michelle A Baum, Yaacov Frishberg, Jaap W Groothoff, Peter C Harris, David J Sas

Kidney Int Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary hyperoxaluria: Long-term outcomes of isolated kidney versus simultaneous liver/kidney transplant.
Nawras W Habash, Rasha A R A Jaoudeh, Roland C Hentz, David J Sas, Samar H Ibrahim

J Pediatr Gastroenterol Nutr· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial.
Yaacov Frishberg, Wesley Hayes, Hadas Shasha-Lavsky, David J Sas, Mini Michael

Front Pediatr· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
David J Sas, Kristin Mara, Ramila A Mehta, Barbara M Seide, Carly J Banks

Pediatr Nephrol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examination of nutritional factors associated with urolithiasis risk in plant based meat alternatives marketed to children and infants.
Garrett N Ungerer, Christine W Liaw, Aaron M Potretzke, David J Sas, Patricio C Gargollo

J Pediatr Urol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Satisfaction Scores Impact Pediatrician Practice Patterns, Job Satisfaction, and Burnout.
David J Sas, Imad Absah, Sean M Phelan, Avni Y Joshi, Ana L Creo

Clin Pediatr (Phila)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Treatment of Primary Hyperoxaluria Type 2 with a Combined Liver and Kidney Transplant.
Kareem M Genena, David J Sas, Dawn S Milliner, John C Lieske

Kidney Int Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Site and Type of Genetic Variation Impact the Resulting Dent Disease-1 Phenotype.
Muhammad G Arnous, Jennifer Arroyo, Andrea G Cogal, Franca Anglani, Hee Gyung Kang, David Sas

Kidney Int Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial.
Wesley Hayes, David J Sas, Daniella Magen, Hadas Shasha-Lavsky, Mini Michael

Pediatr Nephrol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated GFR Slope Across CKD Stages in Primary Hyperoxaluria Type 1.
Prince Singh, Lisa E Vaughan, Phillip J Schulte, David J Sas, Dawn S Milliner

Am J Kidney Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An investigation of metabolic disturbances, including urinary stone disease, hypothyroidism, and osteoporosis in basal cell nevus syndrome.
Karl M Schlaht, David J Sas, Dawn Marie R Davis, Jennifer L Hand

Pediatr Dermatol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The genetics of kidney stone disease and nephrocalcinosis.
Prince Singh, Peter C Harris, David J Sas, John C Lieske

Nat Rev Nephrol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children.
David J Sas, Daniella Magen, Wesley Hayes, Hadas Shasha-Lavsky, Mini Michael

Genet Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Clinical Trial on the Long-Term Efficacy and Safety of Lumasiran in Patients With Primary Hyperoxaluria Type 1.
Sally A Hulton, Jaap W Groothoff, Yaacov Frishberg, Michael J Koren, J Scott Overcash, David J Sas

Kidney Int Rep· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Cysts in Hypophosphatemic Rickets With Hypercalciuria: A Case Series.
Christian Hanna, Theodora A Potretzke, Maroun Chedid, Laureano J Rangel, Jennifer Arroyo, David J Sas

Kidney Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Insights Regarding Organ Transplantation in Primary Hyperoxaluria Type 1.
David J Sas, John C Lieske

Kidney Int Rep· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease.
Andrea G Cogal, Jennifer Arroyo, Ronak Jagdeep Shah, Kalina J Reese, Brenna N Walton, David J Sas

Kidney Int Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis